Transarterial chemoembolization of unresectable systemic chemotherapy‐refractory liver metastases from colorectal cancer: Long‐term results over a 10‐year period

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Cancer

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ijc.28443PMID 23960002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study

  2023cited by this paper
• Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

  2023cited by this paper
• Chemoembolization for colorectal liver metastases after FOLFOX failure.

  2013cited by this paper
• Oncological Management of Unresectable Liver Metastases

  2012influential reference
• Colorectal liver metastases: an update on palliative treatment options.

  2012cited by this paper
• Chemoembolization of colorectal liver metastases with cisplatin, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol

  2011cited by this paper
• High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.

  2011cited by this paper
• Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?

  2010cited by this paper
• Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review.

  2010cited by this paper
• Chemoperfusion und -embolisation von Lebermetastasen

  2010cited by this paper
• Salvage therapy for liver-dominant colorectal metastatic adenocarcinoma: comparison between transcatheter arterial chemoembolization versus yttrium-90 radioembolization.

  2009cited by this paper
• Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study.

  2009cited by this paper
• Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

  2009cited by this paper
• Radioembolization of colorectal hepatic metastases using yttrium‐90 microspheres

  2009cited by this paper
• Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

  2008cited by this paper
• Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for unresectable hepatic tumors.

  2008cited by this paper
• Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

  2007cited by this paper
• Presurgical chemotherapy in patients being considered for liver resection.

  2007cited by this paper
• Longterm results and prognostic indicators after cryotherapy and hepatic arterial chemotherapy with or without resection for colorectal liver metastases in 224 patients: longterm survival can be achieved in patients with multiple bilateral liver metastases.

  2006cited by this paper
• Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies.

  2006cited by this paper
• Transarterielle Chemoembolisation von Lebermetastasen kolorektaler Karzinome mit abbaubaren Stärkepartikeln (Spherex®)

  2005cited by this paper
• [Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment].

  2005cited by this paper
• [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex): personal investigations and review of the literature].

  2005cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

  2004cited by this paper
• Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases?

  2004cited by this paper
• Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival

  2004cited by this paper
• Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer.

  2003cited by this paper
• Transarterielle Chemoembolisation von Lebermetastasen: Indikationsstellung, Technik, Ergebnisse

  2002cited by this paper
• Liver metastases from colorectal cancer: the turning point.

  2002cited by this paper
• [Transarterial chemoembolization of liver metastases: Indication, technique, results].

  2002cited by this paper
• Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases

  2002cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

  2001cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104).

  1999cited by this paper
• Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.

  1999cited by this paper
• Hepatic metastases: basic principles and implications for radiologists.

  1995influential reference
• Colorectal metastases to the liver: selective chemoembolization.

  1993cited by this paper
• The Natural History of Hepatic Metastases from Colorectal Cancer: A Comparison with Resective Treatment

  1984cited by this paper

• Hepatic metastases management: A comparative review of surgical resection, thermal ablation, and stereotactic body radiation therapy.

  2025cites this paper
• Isolated liver chemoperfusion in a patient with mesenteric leiomyosarcoma and liver metastasis

  2024cites this paper
• Chemoembolization Beyond Hepatocellular Carcinoma: What Tumors Can We Treat and When?

  2024cites this paper
• Repeated use of hybrid isolated chemoperfusion with melphalan in non-resectable liver malignancy

  2024cites this paper
• Spectrum of Imaging Findings and Complications After Hepatic Transarterial Chemoembolization for Liver Tumors

  2024cites this paper
• Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities

  2024cites this paper
• Drug-eluting beads transcatheter arterial chemoembolization combined with systemic therapy versus systemic therapy alone as first-line treatment for unresectable colorectal liver metastases

  2024cites this paper
• American Radium Society Appropriate Use Criteria for the use of liver‐directed therapies for nonsurgical management of liver metastases: Systematic review and guidelines

  2023cites this paper
• Drug-eluting bead transarterial chemoembolization (DEB-TACE) versus conventional transarterial chemoembolization (cTACE) in colorectal liver metastasis: Efficacy, safety, and prognostic factors.

  2023cites this paper
• Combined CT-guided high-dose-rate brachytherapy (CT-HDRBT) and transarterial chemoembolization with irinotecan-loaded microspheres improve local tumor control and progression-free survival in patients with unresectable colorectal liver metastases compared with mono-CT-HDRBT

  2023cites this paper
• Prospective Series of Transarterial Chemoembolization of Metastatic Colorectal Cancer to the Liver with 30–60 μm Microspheres Loaded with Irinotecan

  2023cites this paper
• Interventional radiological therapies in colorectal hepatic metastases

  2023cites this paper
• Successful Combined Treatment of a Patient with Borderline Resectable Liver Metastasis of Colorectal Cancer

  2022cites this paper
• Small-size (40 µm) Beads Loaded with Irinotecan in the Treatment of Patients with Colorectal Liver Metastases

  2022cites this paper
• Treatment of Gastrointestinal Tumor Liver Metastases with the Combination of Apatinib and Transarterial Chemoembolization

  2022cites this paper
• Construction of Novel Prognostic Nomogram for Mucinous and Signet Ring Cell Colorectal Cancer Patients with a Survival Longer Than 5 Years

  2022cites this paper
• The Role of Conventional TACE (cTACE) and DEBIRI-TACE in Colorectal Cancer Liver Metastases

  2022cites this paper
• X-RAY-ENDOVACULAR INTERVENTIONS IN THE TREATMENT OF PATIENTS WITH LIVER METASTASES OF COLORECTAL CANCER AFTER THE TERMINATION OF SYSTEMIC CHEMOTHERAPY

  2022cites this paper
• Hepatosellüler Karsinomda İlaç Yüklenebilir Mikroküreler ile Yapılan Transarteriyel Kemoembolizasyonun Etkinliği: Tek Merkez Deneyimi

  2022cites this paper
• Preoperative transarterial chemoembolization with drug-eluting beads (DEB-TACE) in patients undergoing conversional hepatectomy: a propensity-score matching analysis

  2022cites this paper
• Management of Patients with Synchronous Liver Colorectal Cancer Metastasis

  2022cites this paper
• Bronchial or Pulmonary Artery Chemoembolization for Unresectable and Unablatable Lung Metastases: A Phase I Clinical Trial.

  2021cites this paper
• Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial.

  2021cites this paper
• Efficacy of transcatheter arterial chemoembolization combined with capecitabine and cetuximab in the treatment of colorectal cancer with liver metastasis.

  2021cites this paper
• Review of Intra-Arterial Therapies for Colorectal Cancer Liver Metastasis

  2021cites this paper
• Lebermetastasen - interdisziplinäre Therapie

  2020influential citation
• A multicentre, international, observational study on transarterial chemoembolisation in colorectal cancer liver metastases: Design and rationale of CIREL.

  2020cites this paper
• The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in Colorectal Cancer Liver Metastases: Interim Analysis

  2020cites this paper
• Transarterial chemoembolization of colorectal cancer liver metastasis: improved tumor response by DSM-TACE versus conventional TACE, a prospective, randomized, single-center trial

  2020cites this paper
• Onkologische Embolisation

  2020cites this paper
• Interventional Radiology in Management of Colorectal Carcinoma Metastasis

  2020cites this paper
• Transarterial chemoembolization of unresectable systemic chemotherapy refractory liver metastases: a retrospective single-center analysis

  2020influential citation
• Intraarterial chemotherapy in treatment of unresectable colorectal liver metastases refractory to systemic chemotherapy

  2019cites this paper
• HCC: Transarterial Therapies—What the Interventional Radiologist Can Offer

  2019cites this paper
• Toward a better understanding of the mechanism of action for intra-arterial delivery of irinotecan from DC Bead(TM) (DEBIRI).

  2019cites this paper
• Transarterial Chemoembolisation of Colorectal Liver Metastases with Irinotecan-Loaded Beads: A Bi-institutional Analysis of 125 Treatments in 53 Patients

  2019cites this paper
• Preparation of Drug-Eluting Microspheres Based on Semi-Interpenetrating Polymer Network of Modified Chitosan and Poly(2-acrylamide-2-methylpropanesulfonic acid)

  2019cites this paper
• TREATMENT OF COLORECTAL CANCER WITH INTRAPERITONEAL CHEMOTHERAPY AND LOBAPLATIN

  2019cites this paper
• Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study

  2019cites this paper
• Conversion to resectability using transcatheter arterial chemoembolization alternating with mFOLFOX6 in patients with colorectal liver metastases

  2019cites this paper
• Effect of primary tumor side on survival outcomes in metastatic colorectal cancer patients after hepatic arterial infusion chemotherapy

  2018cites this paper
• Long-term survival after percutaneous irreversible electroporation of inoperable colorectal liver metastases

  2018cites this paper
• Survival of patients with non-resectable, chemotherapy-resistant colorectal cancer liver metastases undergoing conventional lipiodol-based transarterial chemoembolization (cTACE) palliatively versus neoadjuvantly prior to percutaneous thermal ablation.

  2018cites this paper
• Hepatic Arterial Therapy for Colorectal Cancer Liver Metastases

  2018cites this paper
• Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis

  2018cites this paper
• A prognostic nomogram for colorectal cancer liver metastases after percutaneous thermal ablation

  2018cites this paper
• Transarterial Embolization with Small-Size Particles Loaded with Irinotecan for the Treatment of Colorectal Liver Metastases: Results of the MIRACLE III Study

  2018cites this paper
• The Role of Liver-Directed Therapy in Metastatic Colorectal Cancer

  2018cites this paper
• Surgical management of colorectal cancer: the Fudan University Shanghai Cancer Center experience

  2017cites this paper
• Personalizing Locoregional Therapy for Patients with Metastatic Colorectal Cancer

  2017cites this paper
• Liver-directed therapy in metastatic colorectal cancer

  2017influential citation
• An Overview of the Current Management of Bilobar Colorectal Liver Metastases

  2017cites this paper
• Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy

  2017cites this paper
• Prognostic factors for transarterial chemoembolization combined with sustained oxaliplatin-based hepatic arterial infusion chemotherapy of colorectal cancer liver metastasis

  2017cites this paper
• Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy.

  2017cites this paper
• A systematic review and meta-analysis of the utility of repeated versus single hepatic resection for colorectal cancer liver metastases.

  2017cites this paper
• Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization

  2017cites this paper
• Radioembolization as a Treatment Strategy for Metastatic Colorectal Cancer to the Liver: What Can We Learn from the SIRFLOX Trial?

  2016cites this paper
• In vitro study of physical properties of various embolization particles regarding morphology before, during and after catheter passage

  2016cites this paper
• Transarterial Therapy for Colorectal Liver Metastases.

  2016cites this paper
• Local and Systemic Therapies for Liver Metastases

  2016cites this paper
• Safety and efficacy compared between irinotecan-loaded microspheres HepaSphere and DC bead in a model of VX2 liver metastases in the rabbit.

  2015cites this paper
• Inferior Mesenteric Artery Chemoembolization and Chemotherapy for Advanced Rectal Cancer: Report of a Clinical Case

  2015cites this paper
• Transarterial chemoembolization (TACE) for colorectal liver metastases—current status and critical review

  2015cites this paper
• Intrahepatic therapy for liver-dominant metastatic colorectal cancer.

  2015cites this paper
• Interventional Radiology in Benign Liver Tumors

  2015cites this paper
• CT Perfusion Imaging Can Predict Patients' Survival and Early Response to Transarterial Chemo-Lipiodol Infusion for Liver Metastases from Colorectal Cancers

  2015influential citation
• Deformable Dose Reconstruction to Optimize the Planning and Delivery of Liver Cancer Radiotherapy

  2014cites this paper
• Interventionelle Therapie von Lungen- und Lebermetastasen

  2014cites this paper
• Interventionelle Therapie von Lungen- und Lebermetastasen

  2014cites this paper
• Isolated hepatic perfusion for patients with liver metastases

  2014cites this paper
• Current Status of Imaging and Emerging Techniques to Evaluate Liver Metastases From Colorectal Carcinoma

  2014cites this paper